Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biol Reprod ; 91(5): 112, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25273529

RESUMO

In the present work the interaction between bovine herpesvirus 4 (BoHV-4)-infected bovine endometrial stromal cells (BESCs) and interferon gamma (IFNG) was investigated. Starting from the particular tropism of BoHV-4 toward BESCs, a pure population of these cells, free of CD45-positive cells, was prepared and proven to have a bona fide mesenchymal derivation as shown by vimentin-positive and cytokeratin-negative staining. BESCs expressed functional IFNG receptors (IFNGR) 1 and 2 but not IFNG ligand. BESCs transfected with a new reporter construct made by cloning the bovine indoleamine 2, 3-dioxygenase 1 (IDO1) promoter in front of the luciferase reporter gene responded to exogenous IFNG treatment. Further, IFNG-treated or constitutively secreting IFNG BESCs strongly restricted BoHV-4 replication and consequent cytopathic effect. IDO1 expression in BESCs was tightly induced by IFNG and IDO1 was previously shown to be the mediator for some of the IFNG pathogenostatic effects. However, IDO1 inhibitors and IDO1 constitutive expression could not respectively abrogate or recapitulate IFNG effect on BoHV-4-infected BESCs, whereas BoHV-4 immediate early (IE2) gene expression was transcriptionally depressed by IFNG axis activation independently from IDO1 expression; this was further confirmed by revealing a BoHV-4 IE2 gene promoter area containing potential responsive elements interacting with inhibitory transcription factors induced by IFNG in BESCs. The data achieved in this work highlight at least two issues: first, the role of BESCs as target/effector cells for the IFNG; second, the importance of uterine IFNG integrity to control BoHV-4 infection recrudescence from a persistent/latent state to a chronic disease, endometritis.


Assuntos
Endométrio/efeitos dos fármacos , Endométrio/virologia , Herpesvirus Bovino 4/efeitos dos fármacos , Proteínas Imediatamente Precoces/genética , Interferon gama/farmacologia , Transativadores/genética , Replicação Viral/efeitos dos fármacos , Animais , Bovinos , Doenças dos Bovinos/genética , Doenças dos Bovinos/virologia , Células Cultivadas , Feminino , Expressão Gênica/fisiologia , Células HEK293 , Infecções por Herpesviridae/genética , Infecções por Herpesviridae/veterinária , Infecções por Herpesviridae/virologia , Herpesvirus Bovino 4/fisiologia , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Interações Hospedeiro-Patógeno/genética , Humanos , Proteínas Imediatamente Precoces/fisiologia , Indolamina-Pirrol 2,3,-Dioxigenase/genética , Células Estromais/efeitos dos fármacos , Células Estromais/virologia , Transativadores/fisiologia , Infecções Tumorais por Vírus/genética , Infecções Tumorais por Vírus/veterinária , Infecções Tumorais por Vírus/virologia , Replicação Viral/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...